These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Biochemical and immunological evaluation of long term coformycin administration in the mouse. Lukey T; Snyder FF Adv Exp Med Biol; 1984; 165 Pt B():189-92. PubMed ID: 6720427 [No Abstract] [Full Text] [Related]
29. Disposition of homocysteine in rat hepatocytes and in nontransformed and malignant mouse embryo fibroblasts following exposure to inhibitors of S-adenosylhomocysteine catabolism. Svardal AM; Djurhuus R; Refsum H; Ueland PM Cancer Res; 1986 Oct; 46(10):5095-100. PubMed ID: 3756867 [TBL] [Abstract][Full Text] [Related]
30. Determination of S-adenosylhomocysteine in tissues following pharmacological inhibition of S-adenosylhomocysteine catabolism. Helland S; Ueland PM Adv Exp Med Biol; 1986; 195 Pt B():663-6. PubMed ID: 3490128 [No Abstract] [Full Text] [Related]
31. A radioisotope assay for 1-aminocyclopropane-1-carboxylic acid synthase: S-adenosylhomocysteine analogs as inhibitors of the enzyme involved in plant senescence. Miura GA; Chiang PK Anal Biochem; 1985 May; 147(1):217-21. PubMed ID: 4025819 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of phosphoinositide metabolism in human polymorphonuclear leukocytes by S-adenosylhomocysteine. Pike MC; DeMeester CA J Biol Chem; 1988 Mar; 263(8):3592-9. PubMed ID: 2831194 [TBL] [Abstract][Full Text] [Related]
33. Homocysteine enhances the inhibitory effect of extracellular adenosine on the synthesis of proteins in isolated rat hepatocytes. Tinton S; Buc-Calderon P Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):893-6. PubMed ID: 7575424 [TBL] [Abstract][Full Text] [Related]
34. Decreased rate of S-adenosyl-L-homocysteine metabolism: an early event related to transformation in cells infected with Rous sarcoma virus. Pierré A; Richou M; Lawrence F; Robert-Géro M; Vigier P Biochem Biophys Res Commun; 1977 Jun; 76(3):813-9. PubMed ID: 197927 [No Abstract] [Full Text] [Related]
35. Differential effects on growth, homocysteine, and related compounds of two inhibitors of S-adenosylhomocysteine catabolism, 3-deazaadenosine, and 3-deazaaristeromycin, in C3H/10T1/2 cells. Djurhuus R; Svardal AM; Ueland PM Cancer Res; 1989 Jan; 49(2):324-30. PubMed ID: 2910451 [TBL] [Abstract][Full Text] [Related]
36. S-adenosylhomocysteine catabolism and basis for acquired resistance during treatment of T-cell acute lymphoblastic leukemia with 2'-deoxycoformycin alone and in combination with 9-beta-D-arabinofuranosyladenine. Hershfield MS; Kredich NM; Koller CA; Mitchell BS; Kurtzberg J; Kinney TR; Falletta JM Cancer Res; 1983 Jul; 43(7):3451-8. PubMed ID: 6601986 [TBL] [Abstract][Full Text] [Related]
37. Evidence for a substrate cycle between AMP and adenosine in isolated hepatocytes. Bontemps F; Van den Berghe G; Hers HG Proc Natl Acad Sci U S A; 1983 May; 80(10):2829-33. PubMed ID: 6304684 [TBL] [Abstract][Full Text] [Related]
38. Binding capacities of various analogues of S-adenosyl-L-homocysteine to protein methyltransferase II from human erythrocytes. Gillet L; Looze Y; Deconinck M; Léonis J Experientia; 1979 Aug; 35(8):1007-9. PubMed ID: 477857 [TBL] [Abstract][Full Text] [Related]
39. S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase in various tissues of mice given injections of 9-beta-D-arabinofuranosyladenine. Helland S; Ueland PM Cancer Res; 1983 Apr; 43(4):1847-50. PubMed ID: 6831422 [TBL] [Abstract][Full Text] [Related]
40. Effect of undermethylation on mRNA cytoplasmic appearance and half-life. Camper SA; Albers RJ; Coward JK; Rottman FM Mol Cell Biol; 1984 Mar; 4(3):538-43. PubMed ID: 6201720 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]